Method for producing marine algae-derived agarotriose, and use thereof as prebiotic

US11872253B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11872253-B2
Application numberUS-202217724386-A
CountryUS
Kind codeB2
Filing dateApr 19, 2022
Priority dateNov 16, 2017
Publication dateJan 16, 2024
Grant dateJan 16, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a method for producing marine algae-derived agarotriose, and a use thereof as a prebiotic. More specifically, the present invention investigates the characteristics of agarotriose as a prebiotic which is selectively metabolized by probiotic microorganisms, thereby enabling agarotriose to be used as an anti-cancer or anti-inflammatory agent in the fields of food and pharmaceuticals, and enabling agarotriose to be obtained at high yield through efficient purification with minimal loss after enzymatic hydrolysis of a red algae-derived polysaccharide without pre-treatment.

First claim

Opening claim text (preview).

What is claimed is: 1. Amethod for producing agarotriose, the method comprising: (a) reacting any one substrate of agar, agarose or neoagarohexose with a β-agarase of SEQ ID NO:1 or SEQ ID NO:5; (b) reacting the reaction product of step (a) with a neoagarobiose hydrolase of SEQ ID NO: 2 or SEQ ID NO:6, to make a resulting product comprising agarotriose; and (c) purifying the agarotriose from the resulting product through a size-exclusion column. 2. The method of claim 1 , wherein the β-agarase of SEQ ID NO: 1 is an enzyme that is derived from a Bacteroides plebeius DSM 17135 strain, and that uses agar, agarose, or neoagarohexaose as a substrate to degrade the substrate into neoagarotetraose and neoagarobiose. 3. The method of claim 1 , wherein step (a) is performed at 0 to 200 rpm under a temperature condition of 30 to 60° C. for 5 minutes to 12 hours. 4. The method of claim 1 , wherein the neoagarobiose hydrolase of SEQ ID NO:2 is an enzyme that is derived from a Bacteroides plebeius DSM 17135 strain, and that uses neoagarotetraose or neoagarobiose as a substrate to degrade the substrate into agarotriose, galactose, or 3,6-anhydro-L-galactose. 5. The method of claim 1 , wherein step (b) is performed at 0 to 200 rpm under a temperature condition of 25 to 45° C. for 30 minutes to 12 hours.

Assignees

Inventors

Classifications

  • A61K35/44Primary

    Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells · CPC title

  • containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates (indigestible substances A23L33/21) · CPC title

  • Bacteria or derivatives thereof, e.g. probiotics · CPC title

  • A23L33/40Primary

    Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula · CPC title

  • Bifidobacteria · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11872253B2 cover?
The present invention relates to a method for producing marine algae-derived agarotriose, and a use thereof as a prebiotic. More specifically, the present invention investigates the characteristics of agarotriose as a prebiotic which is selectively metabolized by probiotic microorganisms, thereby enabling agarotriose to be used as an anti-cancer or anti-inflammatory agent in the fields of food …
Who is the assignee on this patent?
Univ Korea Res & Bus Found
What technology area does this patent fall under?
Primary CPC classification A61K35/44. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jan 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).